Bioactive constituents of Salvia przewalskii and the molecular mechanism of its antihypoxia effects determined using quantitative proteomics
Autor: | Duo Delong, Wang Shengbiao, Yingjun Yan, Aixia Wang, Xinan Wu, Wang Yafeng, Rongyue He |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Quantitative proteomics
Pharmaceutical Science Context (language use) RM1-950 Biology 030226 pharmacology & pharmacy 01 natural sciences 03 medical and health sciences 0302 clinical medicine Drug Discovery Salvia przewalskii Pharmacology fungi General Medicine biology.organism_classification fructose metabolism salvia przewalskii 0104 chemical sciences 010404 medicinal & biomolecular chemistry Fructose metabolism oxidoreduction systems Complementary and alternative medicine Biochemistry Molecular mechanism Molecular Medicine Hypobaric hypoxia Therapeutics. Pharmacology |
Zdroj: | Pharmaceutical Biology, Vol 58, Iss 1, Pp 469-477 (2020) |
ISSN: | 1744-5116 1388-0209 |
Popis: | Context Environmental hypobaric hypoxia induces several physiological or pathological responses in individuals in high-altitude regions. Salvia przewalskii Maxim (Labiatae) (SPM) is a traditional Chinese herbal medicine and has known antibacterial, antiviral, antioxidant, anti-thrombotic, and anti-depressant activities. Objective This study examined the antihypoxia effects of SPM in vivo. Materials and methods The dried and pulverised of SPM was extracted from root crude drug with 70% ethanol with ultrasound. Male Sprague-Dawley rats were divided into three groups (n = 10): normal group, hypoxia group (altitude of 4260 m), and hypoxia + SPM group (altitude of 4260 m, SPM of 1.0 g/kg/day). The experiment persisted for 4 weeks. The mean pulmonary arterial pressure (mPAP), hypoxia-inducible factor-1α (HIF-1α) mRNA, and lung pathology were analysed using pulmonary artery pressure recorder, quantitative polymerase chain reaction, and histopathological analysis. Moreover, the effects of SPM on lung proteomes during hypoxia were observed by a TMT-based proteomic approach. Results Pre-treatment with SPM decreased mPAP (24.86%) and HIF-1α (31.24%), and attenuated the pathological changes in lung tissues. In addition, a total of 28 proteins were differentially expressed in lung of hypoxia + SPM group (fold change > ± 1.2 and p |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |